C
Cellectis SA
CLLS
2.14000
USD
-0.11
(-4.89%)
قبل الجلسة
حجم التداول
5
الربح لكل سهم
0
العائد الربحي
0
P/E
-2
حجم السوق
183,171,352
الأخبار
العنوان: Cellectis SA
القطاع: Healthcare
الصناعة: Biotechnology
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC, product candidates in other therapeutic indications.